statut_color,statut,statut_name,NCTId,eudraCT,CTIS,completion_year,clinical_trial_title,acronym,intervention_type
üü•,3,3: r√©sultats post√©s ou publi√©s apr√®s les 36 mois,NCT00005062,,,2005,A Phase III Trial Comparing High Versus Standard Dose of Prophylactic Cranial Irradiation (PCI) in Limited Small Cell Lung Cancer Complete Responders,,RADIATION
üü•,3,3: r√©sultats post√©s ou publi√©s apr√®s les 36 mois,NCT00126256,,,2006,"Randomized Trial of Treatment Strategy for Chemotherapy in Colorectal Cancer, FFCD 2000-05",,DRUG
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT00147160,,,2007,Phase II Study of the Combination of Cisplatin + Temozolomide in Malignant Glial Tumours in Children and Adolescents at Diagnosis or in Relapse,,DRUG
üü•,3,3: r√©sultats post√©s ou publi√©s apr√®s les 36 mois,NCT00162656,,,2011,Treatment of Mature B-cell Lymphoma/Leukaemia A SFOP LMB 96/CCG 5961/UKCCSG NHL 9600 Cooperative Study,,DRUG
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT01180335,,,2011,Randomized Trial Comparing Standard Neoadjuvant Chemotherapy to Genomic Driven Chemotherapy Regimen in Patients With Breast Cancer,REMAGUS04,DRUG
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT00936156,,,2012,,,DRUG
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT00433706,,,2012,Economic Evaluation of Image Guided Radiation Therapy For Prostate Cancer,,PROCEDURE
üüß,2,2: r√©sultats post√©s ou publi√©s entre 12 et 36 mois,NCT00552149,,,2012,"A Multicenter, Randomized Phase II Trial Assessing the Activity of Gemcitabine - Oxaliplatin Chemotherapy Alone or in Combination With Cetuximab in Patients With Advanced Biliary Cancer.",,DRUG
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT02220049,,,2013,Phase I Dose Escalation of Velcade (Bortezomib) Daily Dose in Patients With Advances or Metastatic Solid Tumors,VELDAY,DRUG
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT02666690,,,2013,Study of the Intra-patient Variability of the Quantitative Parameters of Tumor Perfusion Evaluated With Ultrasound Contrast,VARIA-DCE-US,DEVICE
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT02246244,,,2013,"Randomized, Double Blind, Efficacy Study of Escitalopram Versus Placebo in ENT Cancer Patients Suffering From Emotional Distress",TADDOR,DRUG
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT02515877,,,2013,Modulation of the Expression of Papillomavirus (HPV) Oncoproteins to Major the Radiosensitivity: Phase I Trial Combining an Antiviral Agent VISTIDE and Radiochemotherapy in Cervical Cancers,HPV-RX,RADIATION
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT01486251,,,2014,Assessment of the Tumor Vascular Effects of the Pan-vegfr Tyrosine Kinase Inhibitor Axitinib Using Dynamic Contrast-enhanced Ultrasonography (Dce-us) in Patients With Refractory Metastatic Colorectal Cancer,AXUS,DRUG
üü•,3,3: r√©sultats post√©s ou publi√©s apr√®s les 36 mois,NCT01459003,,,2014,Evaluation of Beauty Care Before Chemotherapy in Women With Breast Cancer,BEAUTY,OTHER
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT02516995,,,2014,Functional Magnetic Resonance Imaging for High Throughput Curietherapy Planning in Prostate Cancer,FIBROP,DEVICE
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT00949039,,,2014,,,RADIATION
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT00359645,,,2015,DEPISTORL - THANCS (Trial of Head And Neck Cancer Screening) Randomized Multicenter Trial to Assess the Impact of a Screening Program for Heavy Alcohol Drinkers and Smokers Treated in Alcohol Addiction Clinics on Upper Aerodigestive Tract Cancer Mortality.,,PROCEDURE
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT01159288,,,2015,Phase II Trial of a Vaccination With Tumor Antigen-loaded Dendritic Cell-derived Exosomes on Patients With Unresectable Non Small Cell Lung Cancer Responding to Induction Chemotherapy,CSET 1437,BIOLOGICAL
üüß,2,2: r√©sultats post√©s ou publi√©s entre 12 et 36 mois,NCT01786031,,,2015,Prostate Cancer Evaluation of TaRgets in Genito Urinary Screening Program,PETRUS,OTHER
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT02217956,,,2015,"Phase I Study of Cisplatin Hyperthermic Intraperitoneal Chemotherapy Dose Escalation After Surgery in Patients With Unresectable Stage IIIC Ovarian, Tube or Peritoneal Primary Adenocarcinoma Previously Treated by Chemotherapy and Completed by Bevacizumab for 15 Months",CHIPASTIN,DRUG
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT00918320,,,2015,Phase 2 Single- Arm Studies of Temozolomide in Combination With Topotecan in Refractory and Relapsed Neuroblastoma and Other Paediatric Solid Tumours,TOTEM2,DRUG
üü•,3,3: r√©sultats post√©s ou publi√©s apr√®s les 36 mois,NCT01112254,,,2015,Evaluation of the Diagnostic Performance of MRI¬±Biopsy to Optimize Resection of Ductal Carcinoma In Situ (DCIS) Breast Cancer,IRCIS,PROCEDURE
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT01677884,,,2016,Intra-arterial Hepatic Bevacizumab and Systemic Chemotherapy in Hepatic Metastases of Metastatic Colorectal Cancer: a Phase II Multicentric Study With Patients in Progression After First Line Systemic Chemotherapy,BEVIAC,DRUG
üü•,3,3: r√©sultats post√©s ou publi√©s apr√®s les 36 mois,NCT01884922,,,2016,"PHASE I-II STUDY OF VINBLASTINE IN COMBINATION WITH NILOTINIB IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS WITH REFRACTORY OR RECURRENT LOW-GRADE GLIOMA",VINILO,DRUG
üü•,3,3: r√©sultats post√©s ou publi√©s apr√®s les 36 mois,NCT02094391,,,2016,"A Randomized, Open Label, Multicenter, Comparative Phase II Trial of Ipilimumab After Isolated Limb Perfusion (ILP), in Patients With In-transit Metastases Melanoma Stage IIIB and IIIC",ILP+/-IPI,DRUG
üü©,1,1: r√©sultats post√©s ou publi√©s dans les 12 mois,NCT02131480,,,2016,A Multicentric Phase II Trial Studying Efficacy of Doxorubicin Associated With Trabectedin (Yondelis) in First Line Treatment on Patients With Metastatic Leiomyosarcoma (Uterus or Soft Tissue) and/or Inoperable Relapse,LMS02,DRUG
üüß,2,2: r√©sultats post√©s ou publi√©s entre 12 et 36 mois,NCT02018874,,,2016,"A Phase Ib, Open-label, Dose Escalation Study of the Safety, Tolerability and Efficacy of LY2780301 (a p70/AKT Inhibitor) in Combination With Gemcitabine in Patients With Advanced or Metastatic Cancer",INPAKT,DRUG
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,,2009-012430-70,,2016,Etude de phase II multicentrique √©tudiant l‚Äôefficacit√© de la doxorubicine associ√©e √† de la trabectedine (Yondelis)  en premi√®re ligne dans le traitement des patients pr√©sentant un l√©iomyosarcome m√©tastatique (ut√©rin ou des tissus mous) et/ou en rechute inop√©rable,LMS02,
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT01706016,,,2016,"Local Treatment by Thermic Destruction of Primitive Breast Cancer. Phase II: Feasibility and Effectiveness, Standardization of Procedures.",LASERBREAST1,PROCEDURE
üüß,2,2: r√©sultats post√©s ou publi√©s entre 12 et 36 mois,NCT02008734,,,2016,Randomized Short-term Pre-surgical Study to Assess the Effects of PD 0332991 in Early Breast Cancer Patients,POP,DRUG
üü•,3,3: r√©sultats post√©s ou publi√©s apr√®s les 36 mois,NCT02040064,,,2016,"Phase I, Open-label, Safety, Tolerability and Preliminary Efficacy Study of Tremelimumab in Combination With Gefitinib in EGFR Mutant NSCLC Patients",GEFTREM,DRUG
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT01834950,,,2017,Identification of Early Markers of Response and Resistance to Trastuzumab in Patients With Localized Human Epidermal Growth Factor Receptor-2(HER-2)-Positive Breast Cancer Candidates for Breast Conserving Surgery,HERBIN,OTHER
üü•,3,3: r√©sultats post√©s ou publi√©s apr√®s les 36 mois,NCT01626638,,,2017,Clinical Evaluation of Confocal Microscopy in Head and Neck Cancer,MEC ORL,PROCEDURE
üü©,1,1: r√©sultats post√©s ou publi√©s dans les 12 mois,NCT01464086,,,2017,,LIFSCREEN,OTHER
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT01211938,,,2017,Randomized Phase 2 Trial Evaluating the Acute Toxicity of Two Protocols of Reirradiation After Surgery in an Irradiated Area for Carcinoma of the Upper Aerodigestive Tract - Single-fraction Radiotherapy With Concomitant 5FU and Hydrea Administered Every Other Week - Continuous Hyperfractionated Radiotherapy With Concomitant Cetuximab,JANORL2,RADIATION
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,,2009-017000-83,,2018,Essai de phase II √©valuant l‚Äôeffet curatif de la pravastatine chez des patients pr√©sentant une fibrose cutan√©e et sous-cutan√©e radio-induite √©tablie,PravaCUR,
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT02488369,,,2018,Study on the Diagnostic Qualities of the Positron Emission Tomography Coupled to the Scanner (PET / CT) in the Assessment of Response to Non-Hodgkin's Lymphoma Therapy in Children and Adolescents,TEP-LYMPHOME,DEVICE
üüß,2,2: r√©sultats post√©s ou publi√©s entre 12 et 36 mois,NCT02523612,,,2018,Prospective National Multicentre Study to Validate a Model of Surgical Deescalation in Atypicals Breast Lesions,NOMAT01,PROCEDURE
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT02831530,,,2018,Randomized Short-term Pre-surgical Study to Assess the Effects of Abemaciclib (LY2835219) in Early Breast Cancer Patients,ABC-POP,DRUG
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT02672527,,,2018,A Randomized Phase III Trial Comparing Trabectedin (Yondelis¬Æ) to the Best Supportive Care in Patients With Advanced Soft Tissue Sarcoma,TSAR,DRUG
üüß,2,2: r√©sultats post√©s ou publi√©s entre 12 et 36 mois,NCT02390934,,,2019,Single Arm Phase II Trial Evaluating the Efficacy of Radium 223 in Radioactive Iodine Refractory Bone Metastases From Differentiated Thyroid Cancer,RAD-THYR,RADIATION
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT03212651,,,2019,A Phase II Study Evaluating Neoadjuvant Pembrolizumab Monotherapy in Patients With Muscle-Invasive Bladder Cancer to Explore in Vivo the Mechanisms of Action of Pembrolizumab,PANDORE,DRUG
üüß,2,2: r√©sultats post√©s ou publi√©s entre 12 et 36 mois,NCT02994225,,,2019,Axillary Reverse Mapping Using Near-infrared Imaging in Invasive Breast Cancer: Predictors of Nodal Positivity,ARMONIC,DRUG
üü©,1,1: r√©sultats post√©s ou publi√©s dans les 12 mois,NCT01268202,,,2019,Curative Efficacy of Pravastatine in Patients Presented Delayed Cutaneous and Subcutaneous Radio-induced Fibrosis,PRAVACUR,DRUG
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT01540058,,,2019,A Randomised Phase III Trial Comparing a Strategy Based on Molecular Analysis to the Empiric Strategy in Patients With Carcinoma of an Unknown Primary (CUP),GEFCAPI04,OTHER
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT03981666,,,2019,Systematic Self-screening of Insomnia and Proposition of a Video-Based Cognitive Behavioral Therapy for Insomnia in Adults Cancer Patients and Survivors: A Pilot Study,SLEEP-4-ALL,OTHER
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT01856296,,,2019,WINTHER: A Study to Select Rational Therapeutics Based on the Analysis of Matched Tumor and Normal Biopsies in Subjects With Advanced Malignancies,WINTHER,PROCEDURE
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT02902874,,,2020,Study of the Biological Mechanisms Associated With the Immunogenicity in Anaplastic Large Cell Lymphoma ( ALCL ) ALK +,Immuno ALCL,OTHER
üü•,3,3: r√©sultats post√©s ou publi√©s apr√®s les 36 mois,NCT00006455,,,2020,International Protocol for the Treatment of Childhood Anaplastic Large Cell Lymphoma,ALCL 99,DRUG
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT01884623,,,2021,Multicentric Randomized Phase III Trial Comparing Methotrexate and Cetuximab in First-line Treatment of Recurrent and/or Metastatic Squamous Cell Head and Neck Cancer in Elderly Unfit Patients According to Geriatric Evaluation,ELAN-UNFIT,DRUG
üü©,1,1: r√©sultats post√©s ou publi√©s dans les 12 mois,NCT02997358,,,2021,Randomised Phase III Multicentric Study Comparing Efficacy of Doxorubicin With Trabectedin Followed by Trabectedin in Non-progressive Patients Versus Doxorubicine Alone as First-line Therapy in Patients With Metastatic or Unresectable Leiomyosarcoma (Uterine or Soft Tissue),LMS04,DRUG
üü©,1,1: r√©sultats post√©s ou publi√©s dans les 12 mois,NCT01371201,,,2021,First International Randomized Study in Malignant Progressive Pheochromocytoma and Paraganglioma (PPGL),FIRSTMAPPP,DRUG
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT02857569,,,2022,A Randomized Phase I/II Trial Evaluating the Safety & Efficacy of Intra-Tumoral Ipilimumab in Combination With Intra-venous Nivolumab in Patients With Metastatic Melanoma,NIVIPIT,DRUG
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT02994576,,,2023,A Single-arm Phase 2 Study of Atezolizumab as Induction Therapy in Stage IB-IIIA Non N2 Resectable and Untreated Non-small Cell Lung Cancer (NSCLC),PRINCEPS,DRUG
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT04775121,,,2023,Classical Monocyte Kinetics in Chronic Myelomonocytic Leukemia,MONOLIFE,OTHER
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT03596281,,,2023,An Open-label Phase 1 of Pembrolizumab in Combination with Bevacizumab and Pegylated Liposomal Doxorubicin in Patients with Platinum Resistant Epithelial Ovarian Cancer,PEMBOV,DRUG
üü©,1,1: r√©sultats post√©s ou publi√©s dans les 12 mois,NCT02494973,,,2024,Postoperative Hepatic Arterial Chemotherapy in High-risk Patients as Adjuvant Treatment After Resection of Colorectal Liver Metastases - A Randomized Phase II/III Trial,PACHA-01,DRUG
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT04267146,,,2024,Phase I-II Study of Nivolumab in Combination With Temozolomide and Radiotherapy in Children and Adolescents With Newly Diagnosed High-grade Glioma,NIVOGLIO,RADIATION
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,,2018-002688-24,,2024,Phase I-II study of nivolumab in combination with temozolomide and radiotherapy in children and adolescents with newly diagnosed high-grade glioma,NIVOGLIO,
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT00407433,,,,Phase 2 Single-Arm Studies of Gemcitabine in Combination With Oxaliplatin Refractory and Relapsed Pediatric Solid Tumors,,DRUG
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT00412503,,,,Phase 1 Study of Temozolomide Associated With Topotecan in Refractory or Relapsed Malignant Tumors in Children and Adolescents,,DRUG
üü•,3,3: r√©sultats post√©s ou publi√©s apr√®s les 36 mois,NCT00002823,,,,A LARGE-SCALE TRIAL EVALUATING ADJUVANT CHEMOTHERAPY AFTER CURATIVE RESECTION OF NON-SMALL CELL LUNG CANCER,,RADIATION
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT00162708,,,,A Randomized Trial Evaluating a Very Intense Radiotherapy-Chemotherapy Regimen Versus a Very Accelerated Radiotherapy in Advanced Head and Neck Squamous Cell Carcinoma,,PROCEDURE
üü•,3,3: r√©sultats post√©s ou publi√©s apr√®s les 36 mois,NCT00180908,,,,"SFOP-OS94: Multicentric Randomised Phase III Trial Comparing Efficacy of Preoperative High-Dose Methotrexate Plus Doxorubicin to Efficacy of High-Dose Methotrexate Plus Etoposide and Ifosfamide, in Children and Adolescents Osteosarcoma",,DRUG
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT00180856,,,,A Phase II Study of Radiofrequency Ablation of Lung Tumors,,PROCEDURE
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT00544349,,,,Phase II Study Evaluating the Effectiveness of the Association of Chemotherapy LV5FU2 Simplified and Cetuximab With Intra-arterial Hepatic Chemotherapy Using Oxaliplatin in Patients With Colorectal Cancer and Nonresectable Hepatic Metastases,,BIOLOGICAL
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,NCT00180869,,,,A Randomized Study of Unmodified Versus Leuko-Reduced Allogeneic Red Blood Cells Transfusion During Surgery in Cancer Patients,,PROCEDURE
üü•,3,3: r√©sultats post√©s ou publi√©s apr√®s les 36 mois,NCT00418327,,,,"Phase I Studies of TarcevaTM (Erlotinib Hydrochloride, OSI-774) as Single Agent in Children With Refractory and Relapsed Malignant Brain Tumors and in Combination With Irradiation in Newly Diagnosed Brain Stem Glioma",,DRUG
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,,2017-001606-14,,,"A study of patient preference between ODM-201 and Enzalutamide in men with metastatic castrate-resistant prostate cancer 
 
 
 Etude de pr√©f√©rence des patients entre l‚ÄôODM-201 et l‚ÄôEnzalutamide chez des hommes atteints d‚Äôun cancer de la prostate m√©tastatique r√©sistant √† la castration",ODENZA Preference,
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,,2018-001744-62,,,"A multicenter, open label, phase II basket trial exploring the efficacy and safety of the combination of rucaparib (PARP inhibitor) and atezolizumab (anti-PD-L1 antibody) in patients with DNA repair-deficient or platinum-sensitive solid tumors 
 
 
 Etude de phase II multi-cohorte multicentrique  √©valuant  l‚Äôefficacit√© et la s√©curit√© d‚Äôemploi de la combinaison  rucaparib (inhibiteur de PARP) et atezolizumab (anticorps anti-PD-L1) chez des patients dont la tumeur pr√©sente un d√©faut de r√©paration de l‚ÄôADN ou est sensible aux sels de platine",ARIANES,
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,,2019-002507-18,,,"Efficacy and feasibility of pasireotide to reduce clinically relevant digestive leakage after complete cytoreductive surgery (CRS) plus Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) for peritoneal carcinomatosis ‚Äì a phase II randomized multicentric trial 
 
 
 Evaluation de la faisabilit√© et de l‚Äôefficacit√© d‚Äôun traitement par pasireotide dans la r√©duction du taux de fistules digestives s√©v√®res apr√®s chirurgie de cytor√©duction compl√®te suivie de  chimio-hyperthermie intra-p√©riton√©ale pour carcinose p√©riton√©ale ‚Äì Essai de phase 2 randomis√© multicentrique.",PASIREOCHIP,
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,,2017-000742-21,,,Efficacy of a selective MEK (trametinib) and BRAFV600E (dabrafenib) inhibitors associated with radioactive iodine (RAI) for the treatment of refractory metastatic differentiated thyroid cancer with RAS or BRAFV600E mutation,MERAIODE,
‚¨õ,4,4: pas de r√©sultats post√©s ni publi√©s,,2010-019224-31,,,INTERGROUP TRIAL FOR CHILDREN OR ADOLESCENTS WITH B-CELL NHL OR B-AL: EVALUATION OF RITUXIMAB EFFICACY AND SAFETY IN HIGH RISK PATIENTS,Inter-B-NHL ritux 2010,
